VWR CHEMICALS, LLC – Trademark Portfolio
Entity Type: 16
VWR CHEMICALS, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 6 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include NEXT GEL, EZ-VISION, and HISTOCHOICE. The owner is based in RADNOR, PA.
100 MATSONFORD ROAD
RADNOR CORPORATE CENTER, BLDG 1, STE 200
RADNOR, PA 19087
Showing of trademarks Trademarks
Trademark Classifications
VWR CHEMICALS, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does VWR CHEMICALS, LLC have?
VWR CHEMICALS, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 cancelled.
What trademark classes does VWR CHEMICALS, LLC file in?
VWR CHEMICALS, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are VWR CHEMICALS, LLC's most well-known trademarks?
VWR CHEMICALS, LLC's registered trademark portfolio includes well-known marks such as NEXT GEL, EZ-VISION, and HISTOCHOICE. These are among 3 currently registered trademarks in the portfolio.
What is VWR CHEMICALS, LLC's trademark registration success rate?
VWR CHEMICALS, LLC has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.